Background
Idiopathic pulmonary fibrosis (IPF) is a devastating illness characterized by irreversible lung fibrosis [1] . Although the overall prevalence of IPF is not high, the incidence of the disease has recently increased. In Europe and North America, the annual incidence of IPF is estimated to be between 2.8 and 18 cases per 100,000 individuals [2] . The median age of IPF is about 65 years, and men have a higher incidence [3, 4] . Wound healing results in fibrosis and is believed to be the basis for the pathogenesis of IPF and includes the stages of homeostasis, inflammation, cell migration, cell proliferation, and extracellular matrix (ECM) remodeling. IPF may be due to chronic injury of the alveolar epithelium that results in pulmonary fibrosis and structural lung remodeling [5] . However, the etiology of IPF remains unknown.
Currently, IPF is considered to be a result of the interaction between genetic and environmental risk factors [6] , and aging might influence the susceptibility to lung fibrosis, as the incidence of IPF increases with age [7] . Also, genome-wide association studies have shown that some genes related to host defense and epithelial barrier function may also be involved in the pathogenesis of IPF [8] . Among these genes, a variant of the MUC5B promoter region was shown to be involved in the development of IPF [9] . In terms of environmental factors, cigarette smoking has been proposed to be the most common association with IPF [10] . Other inhaled environmental agents include exposure to metal dust or wood dust, sand, and spores from soil [4, 11] . IPF remains a challenging disease to treat, and further studies are needed to improve the understanding of the underlying molecular mechanisms to identify gene targets for the development of novel therapies.
There are a large number of microarray gene expression datasets that are publicly available from the Gene Expression Omnibus (GEO) database. There is an increasing demand to integrate gene expression datasets to obtain more accurate results [12] . There have been no previous studies that have undertaken comprehensive bioinformatics analysis in IPF. Therefore, this study aimed to perform a comprehensive analysis approach by using a robust rank aggregation (RRA) method to identify the differentially expressed genes (DEGs) from several datasets [13] . The connectivity map (CMAP) (https://portals. broadinstitute.org/cmap/) transcriptional expression database was chosen to identify gene-expression signatures associated with IPF, as CMAP represents a valuable tool for establishing the connections between genes, drugs, and diseases and contains over 7000 gene expression profiles reflecting 1309 bioactive compounds [14] . CMAP can be used to identify mechanisms of action of small molecules and identify novel therapeutic targets [15] . The signature of differentially expressed genes (DEGs) can be used to input into the CMAP. Also, weighted gene coexpression network analysis (WGCNA) is a powerful approach for exploring the complex relationships between gene expression profiles and phenotype [16] . Therefore, in the present study, WGCNA was used to build a gene coexpression network and screen important modules in the network, and to filter the hub genes in the essential modules.
Therefore, this study aimed to identify key genes and significant signaling pathways involved in IPF using bioinformatics analysis. DEGs from lung tissue microarray data were identified from patients with IPF and normal controls, and potential gene targets for the treatment of IPF were detected using the CMAP database. WGCNA was used to construct a coexpression network associated with IPF to identify significant modules and hub genes, that may be related to the pathogenesis of IPF.
Material and Methods

Datasets used
The gene expression datasets from idiopathic pulmonary fibrosis (IPF) were downloaded from the Gene Expression Omnibus (GEO) repository (http://www.ncbi.nlm.nih.gov/geo/). The GEO represents the largest resource of public microarray data and is widely used to identify key genes in disease. In this study, there were several selection criteria for data selection that included: (a) gene expression datasets which contained gene chip microarrays; (b) studies comparing gene expressions between patients with IPF and normal control lung tissue; (c) sample size in each chip dataset contained at least ten samples; (d) raw data or processed data were available in these databases; (e) hypersensitive pneumonitis, cryptogenic organizing pneumonia (COP), or respiratory bronchiolitis-interstitial lung disease (RBILD) were not included in this study. Searches were excluded if they did not meet the inclusion criteria.
All patients with IPF included in this study met the diagnostic criteria for IPF based on the American Thoracic Society (ATS) and European Respiratory Society (ERS) consensus statement. Lung tissue samples from the normal control groups were obtained from patients without IPF and included lung cancer patients and lung transplant patients. Ethical approval for this study was not required because the data were downloaded directly from public datasets.
Integrated analysis of gene expression datasets
Microarray data preprocessing were executed using R Project software and Bioconductor packages [17] . The raw microarray data were converted to expression data using the robust multiarray average (RMA) algorithm based on R language [18] . Also, two preprocessed series matrix files were directly downloaded from the GEO repository. Probes were mapped to gene symbols. The average gene expression levels were calculated for genes represented by more than one probe. The differentially expressed genes (DEGs) between patients with IPF and normal controls in each dataset were screened by the Limma package in R [19] . Integrated analysis for the DEGs obtained from the six eligible datasets was performed using the R package (Robust Rank Aggregation), based on a robust rank aggregation (RRA) method. Also, |logFC| ³1 and P<0.05 were used as the cutoff criteria for screening the DEGs.
Screening of small molecules
To identify candidate small molecules, we compared the DEGs with the 1,309 different compounds in the connectivity map (CMAP) used to identify gene-expression signatures associated with IPF. The DEGs were input to CMAP software for analysis, according to the website instructions. Small molecules with negative connectivity scores, representing the compounds that might reverse the input signature, were identified as therapeutic agents. The small molecules with average scores <-0.3 and P<0.05 were selected (Table 1) .
Weighted gene coexpression network analysis (WGCNA)
The WGCNA package was used to construct the coexpression network. GSE32537 which including 119 patients with IPF and 50 normal controls was analyzed by WGCNA. We calculated the coefficient of variation for each gene. The top 5,000 genes with the highest coefficient of variation were selected for further analysis by constructing a weighted gene coexpression network. The appropriate power value was determined when the independence degree was up to 0.9. The merge cut height of 0.3 and the minimal module size of 100 were explored to identify coexpression modules. The modules were randomly color-labeled. Genes that could not be clustered into any given module were assigned to the grey module. The coexpression networks were visualized by Cytoscape software version: 3.6.1 (http://www.cytoscape.org/) [20] . We identified modules that were significantly associated with IPF by calculated the correlation between module eigengenes and clinical features. Finally, the modules that were highly correlated with clinical function were chosen for further analysis.
Identification and validation of hub genes in key modules
Module membership (MM) represented the correlation of gene expression profile with the module eigengene. The top 30 genes with the highest connectivity in key modules were regarded as hub genes and were visualized with Cytoscape. The expression statuses of hub genes in key modules were identified for validation. Venn diagram was plotted using the online JVenn tool to overlap the hub genes in significant modules and DEGs obtained from the RRA analysis [21] .
Functional enrichment analysis
Genes in interest modules were uploaded to the online bioinformatics database Metascape (http://metascape.org/) and underwent Gene Ontology (GO) biological process, cellular component, and molecular function analysis as well as Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis [22] . The number of enriched genes ³3 and P<0.01 were regarded as the cutoff criteria. Only the top ten enriched pathways were extracted.
Results
Microarray datasets for idiopathic pulmonary fibrosis (IPF)
After selection according to the eligibility criteria, six datasets were incorporated into the study: GSE10667 [23] , GSE15197 [24] , GSE21369 [25] , GSE24206 [26] , GSE32537 [27] , GSE110147 [28] (Table 2 ). The main characteristics of these publicly available databases including gender ratio, and age distribution, origin, number of samples, GSE number, platforms, and source types are listed in Table 2 . The number of patients with IPF ranged from 8 to 119, and the number of normal controls ranged from 6 to 50. In total, 191 patients with IPF and 101 normal controls were enrolled in the study.
Robust rank aggregation (RRA) analysis
By using the RRA approach to integrate six microarray datasets, a total of 368 differentially expressed genes (DEGs) comprising 248 upregulated and 120 downregulated genes were obtained (Supplementary Table 1 
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downregulated genes are shown in Figure 1 . Among these DEGs, the roles of some genes in IPF have been validated in previous studies, including KRT5, BPIFB1, and AGER.
Screening for small molecules
The connectivity map (CMAP) database was used to search for small molecules with therapeutic potential in IPF. The small molecules with a high negative connectivity score are presented in Table 1 . Among these potential therapeutic agents, pregnenolone and lycorine showed a smaller P-value and were potential therapeutic targets for IPF.
Weighted gene coexpression network analysis (WGCNA)
According to the order of the coefficient of variation, the 5,000 most variable genes were chosen for WGCNA. Hierarchical clustering analysis was performed, and the results are shown in Supplementary Figure 1 . There were three outlier samples in the 169 samples that included GSM806290, GSM806408, GSM806411 when the threshold was set as 55. Outlier samples were removed from the cohort before further analysis. As shown in Figure 2A , power=5 was chosen as the soft-thresholding to ensure a scale-free network. We set the minimum module size to 100 genes and the minimum cut height for merging of modules at 0.3. The weighted gene coexpression network analysis (WGCNA) identified eight modules ranging in size from 228 to 1808.
There were 45 genes that did not belong to any module were labeled in grey, which were excluded from further analysis. These coexpression modules were constructed and were presented in different colors ( Figure 2B ). Interactions between the eight coexpression modules were then analyzed ( Figure 2C ). To explore the clinical significance of the module, correlations between module eigengenes and clinic traits were analyzed. As shown in Figure 3 , black, blue, magenta, and pink modules were positively correlated with two clinical traits, namely disease status and the St George's score for the severity of IPF. By contrast, yellow, brown, and red modules were found to be negatively associated with disease status and St George's score for severity of IPF.
Also, we found some positive correlations between the black module and smoking pack years. Combined with Figure 4 , we observed that these seven modules yielded two main clusters; one included four modules (black, blue, magenta and pink module) while the other included three modules (yellow, brown and red). Furthermore, two pairs of modules had higher adjacencies, and they were the black and magenta module, yellow and brown module respectively. Also, the module eigengene of the black and yellow module showed a higher correlation with disease status (Figure 3 ). The black module had the strongest positive correlation with IPF (r=0.79; P=4e-37) while the yellow module had the strongest negative correlation with IPF (r=-0.81; P=3e-40). We plot a scatterplot for the correlation between module membership and gene significance in the two key modules, respectively ( Figure 5 ). The coexpression networks were visualized with Cytoscape and are shown in Supplementary Figure 2 .
Identification and validation of hub genes in the key modules
Hub genes may determine the characteristics of a module and play significant roles in biological processes. Consequently, the top 30 genes with the highest degree of connectivity in the black and yellow module were taken as hub genes, including COL14A1, TSHZ2, IL1R2, and SLCO4A1. Figure 6A and 6B showed the top 30 hub genes in the black and yellow module. GSE15197  GSE21369  GSE24206  GSE32537  GSE110147   KRT5  BPIFB1  MMP1  MMP7  GPR87  ZBBX  COL3A1  TMEM45A  IL13RA2  MSMB  CXCL13  CLCA2  PROM1  KRT15  CHST9  CP  TMPRSS4  SFRP2  SPP1  COL1A1  CNTN3  COL14A1  CASC1  DIO2  ARMC3  PLA2G1B  AGER  CA4  SLC6A4  STX11  HSD17B6  CPB2  CLDN18  CRTAC1  GKN2  PLLP  FAM107A  PEBP4  IL1RL1  IL6  LRRN4  FCN3  RND1  AGTR2  STC1  SFTA2  MS4A15  HHIP  BTNL9  GPM6A   4 We used DEGs generated from RRA analysis to validate the expression status of the top two hub genes in the black and yellow module. We overlapped the DEGs and genes in the black and yellow module by plotting a Venn diagram. These four hub genes were present in DEGs and significant modules, indicating their value as potential biomarkers for IPF. The results are presented in Figure 7 .
Functional enrichment analysis
Functional enrichment analysis was performed for the genes in the constructed seven modules. The genes in the black module were mainly enriched in extracellular matrix (ECM) organization, skeletal development, and vasculature development ( Figure 8A ). Genes in the yellow module were enriched in myeloid leukocyte migration, leukocyte activation, and were involved in the immune response and the inflammatory response ( Figure 8B ). Genes in the brown module were mainly enriched in blood vessel development, cell junction organization, and sterol biosynthetic. Genes in the blue module were mainly involved in cilia, motile cilia, and O-glycan processing. Multiple signaling pathways were found to be involved in other modules, including nuclear division in the magenta module, T cell activation in the pink module, and olfactory transduction in the red module. The main results in Gene Ontology (GO) 
Discussion
Idiopathic pulmonary fibrosis (IPF) is a progressive and devastating disease that usually leads to death within five years after diagnosis [29] . The pathogenesis of the disease remains poorly understood. In the current study, we conducted an integrated analysis of gene expression data to explore the molecular pathogenesis of IPF. In this study, the robust rank aggregation (RRA) method, was used to screen significant differentially expressed genes (DEGs) from six independent gene expression datasets. A large number of DEGs were identified from which 248 DEGs were upregulated and 120 DEGs were down-regulated in IPF patient samples compared with control samples.
IPF is the result of chronic inflammation and healing in the lung. This study identified some DEGs that were closely associated with inflammation and healing. It was previously reported that KRT5 was highly expressed in the alveolar regions of the lung in IPF [30] . Also, airway stem cells have been shown to express KRT5 in lung injury [31] . The findings from these previous studies support that KRT5 is associated with the process of healing in the alveolar epithelium. BPIFB1 has also been previously shown to be upregulated in respiratory disease, including in chronic obstructive pulmonary disease (COPD) where it has been associated with disease severity [32] . Also, an ulcer-associated cell lineage plays an important role in the healing process in inflammatory bowel disease, and BPIFB1 is one of the ulcer-associated cell lineage genes [33] . Therefore, it is possible that BPIFB1 plays a significant role in the healing process in IPF.
PLA2G1B, a secreted phospholipase, was among the most downregulated genes in IPF in the present study. There have been few previous studies on PLA2G1B in IPF, and so the aberrant expression of this gene should be validated by future studies. AGER, or advanced glycosylation end product-specific receptor, is one of the DEGs that were significantly down-regulated in the present study. Advanced glycosylation end product (AGE) has been previously shown to inhibit the woundhealing in diabetes by reducing the activity of epidermal stem cells [34] . However, blocking the expression of AGER may facilitate the healing process, which may explain the possible role for AEGR in IPF.
Some candidate molecules with therapeutic potential in IPF were explored based on the use of the connectivity map (CMAP) database to identify gene expression signatures.
Pregnenolone is an inactive precursor of steroid hormones, and its potential functional effects have been previously studied [35] . Pregnenolone therapy has shown beneficial effects in schizophrenia [36] , bipolar depression [37] , and drug dependence [38] . Prospective studies are needed to investigate pregnenolone as a candidate therapeutic compound in IPF. Lycorine is an alkaloid derived from Hymenocallis littoralis, which has antibacterial, antiviral, and wound-healing properties [39] . The findings from a previous study suggested that lycorine might have therapeutic potential in patients with IPF [40] . This previous finding was consistent with the findings from the present study, and lycorine is a molecule that requires further study.
The method of WGCNA that was the basis of this study is an efficient approach to construct coexpressed modules and hub genes in several diseases [41] . In this study, we investigated the gene expression profile of GSE32537, including 119 patients with IPF and 50 normal controls to explore the molecular mechanism of IPF. Using WGCNA, the weighted coexpression network was constructed, and eight coexpression modules were identified. Seven of the modules showed a significant correlation with disease status, which were divided into two clusters, providing new insights into the pathogenesis of IPF. Among the identified modules, the black, blue, magenta, and pink modules were positively associated with disease status, whereas the yellow, brown, and red modules were negatively correlated with disease status. To determine the importance of these coexpression modules in the pathogenesis of IPF, enrichment analysis was performed using the Metascape online bioinformatics gene annotation and analysis database. The black module was found to be mainly enriched in collagen-containing extracellular matrix (ECM) and the ECM component. Increased accumulation of ECM is an important phase of the wound-healing process. ECM has been identified as an active contributor to the progression of fibrosis [42] . A therapeutic approach that targets the ECM may reverse fibrosis and restore lung function. The results of this study showed that the yellow module was mainly enriched in myeloid leukocyte migration and leukocyte activation involved in the immune response, and in cell migration. These results were consistent with previous studies that immune signaling pathways may be protective in IPF [43] .
The black and yellow modules were found to be most significantly correlated with the disease status of IPF. Therefore, we screened the hub genes and validated the top two hub genes in the two modules. These four hub genes were all present in DEGs and significant modules, indicating their important roles in biological processes. COL14A1 is a member of the fibril-associated collagens with interrupted triple helices (FACIT) collagen family, with the main function of collagen binding and ECM components [44] . COL14A1 expression has been reported to be significantly upregulated in the pulmonary artery intima and media of patients with pulmonary arterial hypertension [45] . It is likely that COL14A1 plays a key role in the process of pulmonary interstitial fibrosis.
In this study, TSHZ2, a zinc-finger homeobox gene, was identified as a hub gene. Studies on the role of TSHZ2 are limited, and future studies are required to confirm its function in IPF. IL1R2 is a member of the interleukin-1 receptor family and acts as a negative regulator of the IL-1 system. The anti-inflammatory effect of IL1R2 has been confirmed by in vivo studies, and include chronic skin inflammation [46] , and arthritis [47] . The combination of acute inflammation and healing due to persistent injury results in fibrosis [48] . In the present study, IL1R2 was both a hub gene and a significantly down-regulated gene in the IPF group, suggesting that the overactive wound healing was most likely associated with the functional deletion of IL1R2. SLCO4A1 is a member of solute carrier organic anion transporter family, which is involved in the transport of a variety of compounds [49] . There have been few studies on SLCO4A. However, SLCO4A1 has been shown to have a role in the proliferation of colorectal cancer cell and cell migration in vitro and to be a negative prognostic marker in vivo [50] . Further studies are required to determine the role of SLCO4A1 in IPF.
The key genes identified in this study were associated with the pathogenesis of fibrosis, including in IPF, and the findings 4294 
Conclusions
Through the comprehensive bioinformatics analysis of several gene expression datasets, we identified differentially expressed genes (DEGs) that might be related to the pathogenesis, diagnosis, and prognosis of idiopathic pulmonary fibrosis (IPF). Also, relevant small molecules were predicted using the connectivity map (CMAP) database to identify gene expression signatures associated with IPF, which might be potential candidate therapeutic compounds for IPF. We used weighted gene coexpression network analysis (WGCNA) to build a coexpression network associated with IPF and found two modules and four hub genes, which might identify novel insights into the molecular mechanisms underlying IPF. The findings of this study should be confirmed by future in vitro and clinical studies.
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